Lucie Benesova
Overview
Explore the profile of Lucie Benesova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halkova T, Bunganic B, Traboulsi E, Minarik M, Zavoral M, Benesova L
Genes (Basel)
. 2024 Oct;
15(10).
PMID: 39457426
Although the overall survival prognosis of patients in advanced stages of pancreatic ductal adenocarcinoma (PDAC) is poor, typically ranging from days to months from diagnosis, there are rare cases of...
2.
Frankova V, Svozilova H, Stranecky V, Stano Kozubik K, Srovnal J, Benesova L, et al.
Cas Lek Cesk
. 2023 Mar;
161(7-8):271-275.
PMID: 36868836
The current significant development of human genome/exome sequencing in biomedical research is one of the important paths leading to personalized medicine. However, sequencing of human genetic information generates potentially sensitive...
3.
Buresova M, Benesova L, Minarik M, Ptackova R, Halkova T, Hosek P, et al.
J Cancer
. 2023 Jan;
14(1):1-8.
PMID: 36605490
To investigate potential association between selected tumor markers and laboratory parameters (lactate dehydrogenase [LDH], neutrophils, hemoglobin, neutrophils, lymphocytes, C-reactive protein, albumin, carcinoembryonic antigen, and cytokeratin 19 fragment 21-1 [CYFRA 21-1])...
4.
Benesova L, Ptackova R, Halkova T, Semyakina A, Svaton M, Fiala O, et al.
Pathol Oncol Res
. 2022 Jul;
28:1610308.
PMID: 35837614
Observation of anticancer therapy effect by monitoring of minimal residual disease (MRD) is becoming an important tool in management of non-small cell lung cancer (NSCLC). The approach is based on...
5.
Halkova T, Ptackova R, Semyakina A, Suchanek S, Traboulsi E, Ngo O, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740488
(1) Background: this prospective study was focused on detailed analysis of the mutation heterogeneity in colorectal lesions removed during baseline (index) colonoscopy to identify patients at high risk of early...
6.
Fiala O, Baxa J, Svaton M, Benesova L, Ptackova R, Halkova T, et al.
Cancer Genomics Proteomics
. 2022 Feb;
19(2):270-281.
PMID: 35181593
Background/aim: Circulating tumour DNA (ctDNA) represents an emerging biomarker in non-small cell lung cancer (NSCLC). We focused on the combination of ctDNA and positron emission tomography/computed tomography (PET/CT) in the...
7.
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - A Helicobacter-opposite point
Tacheci I, Repak R, Podhola M, Benesova L, Cyrany J, Bures J, et al.
Best Pract Res Clin Gastroenterol
. 2021 May;
50-51:101728.
PMID: 33975682
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is a rare familial gastric cancer syndrome with an autosomal dominant pattern of inheritance. It is characterised by fundic gland polyposis...
8.
Pazdirek F, Minarik M, Benesova L, Halkova T, Belsanova B, Macek M, et al.
Front Oncol
. 2020 Aug;
10:1028.
PMID: 32793464
Patients with locally advanced rectal cancer (LARC) are undergoing neoadjuvant chemoradiotherapy (NCRT) prior to surgery. Although in some patients the NCRT is known to prevent local recurrence, it is also...
9.
Benesova L, Halkova T, Ptackova R, Semyakina A, Menclova K, Pudil J, et al.
World J Gastroenterol
. 2020 Jan;
25(48):6939-6948.
PMID: 31908397
Background: One of the most notable applications for circulating tumor DNA (ctDNA) detection in peripheral blood of patients with metastatic colorectal cancer (mCRC) is a long-term postoperative follow-up. Sometimes referred...
10.
Benesova L, Halkova T, Bunganic B, Belsanova B, Zavoral M, Traboulsi E, et al.
Pathol Oncol Res
. 2018 Oct;
26(1):379-385.
PMID: 30361898
We compare two types of pancreatic carcinoma samples obtained by EUS-guided fine needle biopsy (EUS-FNB) in terms of the success rates and clinical validity of analysis of two most commonly...